Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma-Reference-Cited by-同舟云学术

Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma

Published:2022-09-01 Issue:5 Volume:42 Page:558-565
ISSN:2234-3806
Container-title:Annals of Laboratory Medicine
language:en
Short-container-title:Ann Lab Med

Author:

Kim Hyun-Young¹^ORCID,Yoo In Young²^ORCID,Lim Dae Jin¹³^ORCID,Kim Hee-Jin¹^ORCID,Kim Sun-Hee¹^ORCID,Yoon Sang Eun⁴^ORCID,Kim Seok Jin⁴^ORCID,Cho Duck¹⁵^ORCID,Kim Kihyun⁴^ORCID

Affiliation:

1. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

2. Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

3. Department of Health and Safety Convergence Science, Korea University, Seoul, Korea

4. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

5. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea

Funder

Samsung Medical Center

Publisher

Annals of Laboratory Medicine

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

http://pdf.medrang.co.kr/ALM/2022/042/ALM042-05-558.pdf

Reference17 articles.

1. Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma

2. Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma

3. Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives

4. Application of Next Generation Sequencing in Laboratory Medicine

5. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Measurable Residual Disease in Pediatric B-Lymphoblastic Leukemia Using Multiparametric Flow Cytometry and Next-Generation Sequencing;Annals of Laboratory Medicine;2024-01-19

2. Current Status of Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasms in Korea;Annals of Laboratory Medicine;2023-12-26

3. Toward Standardization of Flow-Cytometric Immunophenotyping for the Diagnosis and Monitoring of Hematologic Malignancies;Annals of Laboratory Medicine;2023-12-26

4. Validation of High-sensitivity Flow Cytometry for Reliable Immune Cell Analysis in Real-world Laboratory Settings;Annals of Laboratory Medicine;2023-06-30

5. Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia;Annals of Laboratory Medicine;2023-02-24